国际指导方针如何建议治疗患有严重COVID-19或有疾病进展风险的儿童
Joanna Mańdziuk1, Ernest Kuchar1, Magdalena Okarska-Napierała1
1Department of Pediatrics with Clinical Assessment Unit, Medical University of Warsaw, Warsaw, Poland.
Acta paediatrica (Oslo, Norway : 1992)
|July 10, 2024
概括
本综述总结了针对儿童的COVID-19治疗指南,为严重病例和高风险儿科患者选择药物提供了实用方法. 讨论了关键的抗病毒药物和免疫调节剂.
科学领域:
- 儿童传染病 儿童传染病
- 临床药理学 临床药理学
- 基于证据的医学基于证据的医学.
背景情况:
- 在儿科患者群体中,COVID-19带来了独特的挑战.
- 儿科COVID-19治疗的管理指南正在发展.
- 临床医生需要采取综合的药物治疗方法.
研究的目的:
- 审查当前的知识和国际指导方针来管理儿童的COVID-19.
- 为儿童COVID-19提出一个实用的药物治疗策略.
- 综合有效治疗干预的证据.
主要方法:
- 分析主要科学机构的国际治疗指南.
- 包括来自英国NICE,美国NIH,IDSA和澳大利亚特别工作组的指南.
- 对儿科COVID-19的药物建议进行系统审查.
主要成果:
- 大多数儿童COVID-19病例只需要症状治疗.
- 对于严重或高风险的儿科病例存在有限的证据.
- 在高风险儿童的预防中,关于涅马特雷尔维尔/里托纳维尔或雷梅西维尔的共识存在.
- 雷姆迪西维尔适用于严重的COVID-19.
- 对于需要氧气的患者,建议使用葡萄糖皮质类固醇.
- 托西利祖马布或巴里西提尼布仅用于带有全身炎症的进展性疾病.
结论:
- 国际指南为儿童COVID-19药物治疗提供了有价值的见解.
- 对于管理严重或渐进的儿科COVID-19存在一定程度的共识.
- 综合的信息为治疗儿童的临床医生提供了实际的框架.
更多相关视频
09:03Nasal Brushing Sampling and Processing Using Digital High Speed Ciliary Videomicroscopy – Adaptation for the COVID-19 Pandemic
Published on: November 7, 2020
4.7K
09:36Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
Published on: September 24, 2020
2.8K
相关概念视频
01:28Pneumonia IV: Management
317
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
317
01:29Acute Respiratory Failure-V
129
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
129
01:28Pulmonary Tuberculosis V
177
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
177
01:17Transmission-based Precautions I: Contact, Enteric, and Droplets
3.5K
Transmission-based precautions are for patients known to be infected or suspected to be infected or colonized with organisms that pose a significant risk to others. Some transmission-based precautions include contact, enteric, and droplet.
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
3.5K
01:25Transmission-based Precautions II: Airborne and Protective Environment
1.2K
Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
1.2K
01:26Tonsillitis II: Management
107
This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
107